Vanguard Group’s InfuSystem Holdings INFU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$8.8M Buy
981,575
+5,398
+0.6% +$51.7K ﹤0.01% 3026
2025
Q3
$10.1M Buy
976,177
+18,539
+2% +$154K ﹤0.01% 2972
2025
Q2
$5.98M Sell
957,638
-122,638
-11% -$678K ﹤0.01% 3148
2025
Q1
$5.81M Sell
1,080,276
-15,466
-1% -$113K ﹤0.01% 3111
2024
Q4
$9.26M Sell
1,095,742
-24,659
-2% -$194K ﹤0.01% 3000
2024
Q3
$7.51M Buy
1,120,401
+17,517
+2% +$113K ﹤0.01% 3096
2024
Q2
$7.53M Buy
1,102,884
+19,154
+2% +$141K ﹤0.01% 3066
2024
Q1
$9.29M Buy
1,083,730
+18,432
+2% +$173K ﹤0.01% 2998
2023
Q4
$11.2M Buy
1,065,298
+23,976
+2% +$235K ﹤0.01% 2881
2023
Q3
$10M Buy
1,041,322
+16,701
+2% +$171K ﹤0.01% 2876
2023
Q2
$9.87M Buy
1,024,621
+95,409
+10% +$864K ﹤0.01% 2947
2023
Q1
$7.2M Buy
929,212
+46,067
+5% +$424K ﹤0.01% 3127
2022
Q4
$7.67M Buy
883,145
+116,044
+15% +$946K ﹤0.01% 3075
2022
Q3
$5.36M Hold
767,101
﹤0.01% 3290
2022
Q2
$7.39M Sell
767,101
-91,951
-11% -$805K ﹤0.01% 3157
2022
Q1
$8.42M Buy
859,052
+68,242
+9% +$877K ﹤0.01% 3246
2021
Q4
$13.5M Sell
790,810
-153,945
-16% -$2.44M ﹤0.01% 3064
2021
Q3
$12.3M Sell
944,755
-71,578
-7% -$1.17M ﹤0.01% 3127
2021
Q2
$21.1M Buy
1,016,333
+107,578
+12% +$2.18M ﹤0.01% 2810
2021
Q1
$18.5M Buy
908,755
+111,564
+14% +$2.09M ﹤0.01% 2826
2020
Q4
$15M Sell
797,191
-423,438
-35% -$6.38M ﹤0.01% 2784
2020
Q3
$15.6M Buy
1,220,629
+51,787
+4% +$673K ﹤0.01% 2572
2020
Q2
$13.5M Buy
1,168,842
+109,380
+10% +$1.26M ﹤0.01% 2621
2020
Q1
$8.99M Buy
1,059,462
+324,125
+44% +$2.93M ﹤0.01% 2669
2019
Q4
$6.27M Buy
735,337
+131,712
+22% +$970K ﹤0.01% 3089
2019
Q3
$3.19M Hold
603,625
﹤0.01% 3284
2019
Q2
$2.6M Hold
603,625
﹤0.01% 3395
2019
Q1
$3.02M Buy
603,625
+700
+0.1% +$2.79K ﹤0.01% 3325
2018
Q4
$2.07M Hold
602,925
﹤0.01% 3360
2018
Q3
$1.96M Hold
602,925
﹤0.01% 3540
2018
Q2
$2.14M Hold
602,925
﹤0.01% 3478
2018
Q1
$1.75M Buy
602,925
+148,800
+33% +$350K ﹤0.01% 3508
2017
Q4
$1.04M Hold
454,125
﹤0.01% 3603
2017
Q3
$931K Hold
454,125
﹤0.01% 3608
2017
Q2
$817K Hold
454,125
﹤0.01% 3612
2017
Q1
$1.04M Buy
454,125
+68,496
+18% +$156K ﹤0.01% 3565
2016
Q4
$983K Buy
385,629
+3,996
+1% +$8.98K ﹤0.01% 3566
2016
Q3
$1.06M Hold
381,633
﹤0.01% 3555
2016
Q2
$993K Buy
381,633
+9,137
+2% +$28.7K ﹤0.01% 3607
2016
Q1
$1.31M Buy
372,496
+4,189
+1% +$13.2K ﹤0.01% 3519
2015
Q4
$1.12M Buy
368,307
+1,000
+0.3% +$2.87K ﹤0.01% 3585
2015
Q3
$1M Buy
367,307
+229
+0.1% +$677 ﹤0.01% 3634
2015
Q2
$1.17M Buy
367,078
+4,400
+1% +$13.8K ﹤0.01% 3618
2015
Q1
$983K Buy
362,678
+3,000
+0.8% +$8.12K ﹤0.01% 3635
2014
Q4
$1.13M Buy
359,678
+71,139
+25% +$226K ﹤0.01% 3490
2014
Q3
$906K Buy
288,539
+6,000
+2% +$17K ﹤0.01% 3538
2014
Q2
$749K Buy
282,539
+19,100
+7% +$52.6K ﹤0.01% 3564
2014
Q1
$735K Buy
263,439
+56,896
+28% +$147K ﹤0.01% 3549
2013
Q4
$442K Buy
206,543
+163,868
+384% +$287K ﹤0.01% 3624
2013
Q3
$55K Buy
42,675
+23,880
+127% +$35.1K ﹤0.01% 3803
2013
Q2
$28K Buy
+18,795
New +$28.7K ﹤0.01% 3785

Other funds holding INFU

Vanguard Group's INFU Position: Q4 2025 in Review

Vanguard Group increased its InfuSystem Holdings (INFU) stake by 0.55% in Q4 2025, buying an estimated $51.7K and bringing the position to 981,575 shares worth $8.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3026.

Vanguard Group first reported a position in INFU in Q2 2013 and has held it in 51 quarters since. The position peaked at $21.1M in Q2 2021. 102 funds tracked by Wall St. Rank hold INFU as of Q4 2025.

  • Vanguard Group held 981,575 shares of InfuSystem Holdings worth $8.8M as of Q4 2025.
  • Vanguard Group bought 5,398 InfuSystem Holdings shares in Q4 2025, an estimated $51.7K.
  • InfuSystem Holdings made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3026 holding.
  • Vanguard Group first reported a position in InfuSystem Holdings in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's InfuSystem Holdings position peaked at $21.1M in Q2 2021.
  • 102 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.